Marc Chimowitz to Risk Assessment
This is a "connection" page, showing publications Marc Chimowitz has written about Risk Assessment.
Connection Strength
0.591
-
Re: Turk et al and the "how do we spin wingspan?" commentary. AJNR Am J Neuroradiol. 2008 Sep; 29(8):e69; author reply e70.
Score: 0.189
-
Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104713.
Score: 0.107
-
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011 Jul-Aug; 20(4):357-68.
Score: 0.059
-
Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging. 2011 Apr; 21(2):e159-61.
Score: 0.058
-
Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 2006 Oct 10; 67(7):1275-8.
Score: 0.043
-
Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Cerebrovasc Dis. 2019; 47(1-2):24-31.
Score: 0.025
-
Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis. J Neuroimaging. 2015 Jan-Feb; 25(1):87-91.
Score: 0.018
-
Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013 May; 72(5):777-95; discussion 795.
Score: 0.017
-
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):e51-60.
Score: 0.016
-
Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke. 2008 Mar; 39(3):1039-41.
Score: 0.012
-
Echocardiography in patients with symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis. 2007 Sep-Oct; 16(5):216-9.
Score: 0.011
-
Leukocyte count and vascular risk in symptomatic intracranial atherosclerosis. Cerebrovasc Dis. 2007; 24(2-3):283-8.
Score: 0.011
-
Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Circulation. 2003 Sep 09; 108(10):1278-90.
Score: 0.009
-
Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke. 2003 Sep; 34(9):2310-22.
Score: 0.009
-
Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke. 2002 Dec; 33(12):2762-8.
Score: 0.008